The incidence of chronic kidney disease (CKD) has increased in recent years. CKD is associated with obesity, type 2 diabetes, and cardiovascular disease, although the mechanism remains unclear. Elevated soluble form of the receptor for advanced glycation end products ( RAGE) is related to proinflammatory signaling pathways that may promote diabetic nephropathy and vascular dysfunction. Because lifestyle modification reduces systematic inflammation in adults with obesity and hyperglycaemia, the hypothesis that exercise plus caloric restriction would lower soluble RAGE in adults with CKD was tested in this study. Methods: Eight adults (n = 6 females; age: 56.3 ± 2.8 y; BMI: 43.7 ± 2.2 kg/m 2 ; 2-h OGTT glucose: 215 ± 9.8 mg/dL; eGFR: 49.6 ± 3.3 mL/min/1.73 m 2 ) were enrolled in a 12-week pilot lifestyle intervention (supervised aerobic exercise [5 d/wk, up to 60 min/d at approximately 65%-85% HR max ] plus low-fat dietary counseling). Body composition (DXA), aerobic fitness (VO 2 max), insulin sensitivity (120 min 75 g OGTT; Matsuda Index), plasma levels of soluble RAGE and fetuin-A were measured before and after the intervention.
intolerance, and insulin resistance. 3 Indeed, insulin resistance is tightly associated with inflammation, 4 and there is growing evidence that advanced glycation end products (AGEs), and their receptors are increased during conditions of inflammation. 5 In fact, receptor for AGEs (RAGE) activates cellular signalling pathways, such as nuclear factor-κB, thereby resulting in disturbances in oxidative stressmediated vascular dysfunction. 6 As such, RAGE is a novel member of a group of immunoglobins that are implicated in the development of atherosclerosis, metabolic syndrome, and type 2 diabetes. 7 Interestingly, mice that genetically overexpress RAGE have increased diabetic nephropathy compared with RAGE null mice who do not develop kidney dysfunction. 8 However, the soluble form of RAGE has been suggested to prevent the development and progression of atherosclerosis in diabetic apo-E-null mice by acting as a decoy for AGEs. 9 To date, controversy exists surrounding soluble RAGE,
with several studies reporting that it is elevated in adults with type 2 diabetes 10,11 and impaired renal function 12 but lower in adults with essential hypertension and coronary heart disease. 12, 13 Therefore, determining the effect of treatments on soluble RAGE is paramount to understanding cardiometabolic risk reduction mechanisms and relevance in people with CKD. Exercise and weight loss interventions reduce cardiometabolic risk by, at least partially, lowering inflammation (eg, fetuin-A and leptin) related to insulin resistance in adults with obesity. [14] [15] [16] As a result, exercise and diet are recommended as a firstline therapy in weight management and glycemic control. Exercise with weight loss generally improves endothelial function and glucose regulation via reductions in inflammation in adults with CKD, 17, 18 although not all studies agree. 19 Nevertheless, based on the established health benefits of weight loss, it would seem that soluble RAGE should decrease after interventions aimed at improving insulin sensitivity for glycaemic control in adults with CKD. 17 However, data on the effect of exercise and/or weight loss on soluble RAGE are equivocal, with some showing reductions, 20 increases, 21 or no change. 22, 23 These studies are limited though to patients with obesity, who have or do not have type 2 diabetes, and there are no data determining the effect of an exercise plus diet intervention programme on soluble RAGE in adults with CKD. To address this gap in the literature, this study tested the hypothesis that lifestyle-induced weight loss would decrease plasma soluble RAGE in conjunction with improved glucose regulation.
| METHODS

| Participants
Eight adults (56.3 ± 2.8 y, BMI: 43.7 ± 2.1 kg/m 2 , Table 1 ) with CKD (eGFR: 49.6 ± 3.3 mL/min/1.73 m 2 ) volunteered for this study after being identified using electronic medical records. Although some cardiometabolic data were previously reported, 17 the data are provided here for convenience. All participants were nonsmoking, weight stable (<2 kg in the previous 6 months), sedentary (less than <60 min/wk), and had blood pressure < 180/110 mmHg, HbA 1c < 8%, and an eGFR < 60 mL/min/1.73 m 2 . Participants were verbally briefed about the study and signed written informed consent documents approved by the Cleveland Clinic Institutional Review Board.
| Exercise training
Participants were screened with a resting ECG and an incremental maximally graded exercise stress test before participation in the intervention to ensure cardiac function and safety. Participants underwent a supervised progressive treadmill-walking exercise intervention Insulin sensitivity (au) 1.9 ± 0.5 2.5 ± 0.5 .02
Note. Data reported as mean ± SEM. Insulin sensitivity was estimated via the Matsuda Index. Abbreviations: AUC = total area under the curve; PG = plasma glucose; PI = plasma insulin; WC = waist circumference. 
| Dietary intervention
At baseline, resting metabolic rate (RMR) was examined after participants rested in the supine position for 30 minutes following an over- 
| Cardiometabolic risk
Resting HR as well as systolic and diastolic blood pressure was recorded in the seated position after approximately 10 minutes of rest. Fasting glucose, insulin, fetuin-A, and soluble RAGE were obtained from an antecubital vein. A standard 75-g oral glucose tolerance test (OGTT) was performed to measure postprandial glucose and insulin as previously described. 24 
| Statistical analysis
Pre-group and post-group means were compared using the statistical programme R (Mavericks build, R Foundation, Vienna, Austria, 2014).
Non-normally distributed data were log transformed for statistical analysis. All outcomes were assessed using a paired, two-tailed t test.
Spearman-ranked correlation analysis was used to determine associations between variables, and significance was accepted as P < .05.
Data are expressed as mean ± standard error of the mean.
| RESULTS
| Fitness and body composition
Exercise and diet significantly reduced body weight by −4.1 ± 0.6% (P < .001), and this effect was predominately due to a decrease in fat mass (−4.6 ± 0.7%, P < .001) since fat-free mass was unchanged at the end of the intervention (0.2 ± 1.0%, P = .74; Table 1 ). Exercise training increased VO 2 max (mL/kg/min) by approximately 16.9 ± 2.9% (P < .001).
| Cardiometabolic risk factors
The intervention had no significant effect on lowering resting HR or blood pressure ( 
| Soluble RAGE and correlations
Exercise training with weight loss significantly decreased plasma soluble RAGE (pre = 1018.1 ± 163.0 vs post = 810.6 ± 119.6 ng/mL, P = .02; Figure 1 ). These lower soluble RAGE levels were associated with reductions in 2-hour blood glucose (r = 0.76, P = .03, Figure 2A ) and improved insulin sensitivity (r = −0.90, P < .01, Figure 2B ). The correlation between changes in body weight (r = −0.57, P = .15), VO 2 max (r = −0.25, P = .59), and iGRF (r = 0.02, P = .97) with reductions in soluble RAGE were not statistically significant.
| DISCUSSION
The main finding from this study is that exercise training plus caloric restriction decreased plasma soluble RAGE concentrations (Figure 1 ).
The reduction in soluble RAGE was significantly correlated with lower circulating postprandial glucose and increased insulin sensitivity ( Figure 2 ). These findings are consistent with a recent report that increasing physical activity led to a reduction in soluble RAGE in elderly adults with normoglycemia. 20 In contrast, Danzig et al 23 reported that a single bout of aerobic exercise performed to maximal HR had no effect on soluble RAGE in adults with coronary artery disease. Further adding to the opposing findings, Choi et al 21 The mechanism by which lifestyle-induced weight loss reduces soluble RAGE has yet to be fully elucidated. Physically active individuals typically have more favourable cardiometabolic profiles than less active people. 26 However, no such correlation of fitness and RAGE was detected in this study, suggesting VO 2 max is unlikely a primary mechanism underlying the reduction in RAGE. Alternatively, renal clearance may be an important factor regulating the removal of AGEs 27 that, in turn, would impact expression of soluble RAGE. Prior work 17 though showed that 12 weeks of lifestyle-induced weight loss had no effect on kidney function as measured by iGFR, and no such association with soluble RAGE was observed with this same approach in the present study. Thus, changes in soluble RAGE after lifestyle treatment appear independent of renal function. Weight loss on the other hand is established to reduce cardiometabolic disease risk, 28 and some, 20 but not all, 21, 29 have proposed that decreased body weight per se is directly correlated with reductions in soluble RAGE.
While the results presented here are consistent with lifestyle-induced weight loss altering soluble RAGE in patients with CKD, further work is warranted. Nonetheless, another possible mechanism by which weight loss could have reduced soluble RAGE relates to circulating glucose. Hyperglycaemia induces nonenzymatic alterations in extracellular and intracellular proteins, thereby promoting AGEs and increasing the expression of RAGE. 30, 31 Although the current study did not measure AGEs, it is worth noting that caloric restriction and 12-weeks of aerobic exercise decrease AGEs. 32, 33 Further, a direct Exercise combined with caloric restriction has been show to improve insulin sensitivity 34 in part through lower inflammation. 15, 35 Herein, while lifestyle-induced weight loss was shown to decrease circulating fetuin-A in patients with CKD, no significant correlation with insulin sensitivity was noted. In contrast, the results of the present study suggest that changes in soluble RAGE after lifestyle-induced therapy were associated with improvements in insulin sensitivity ( Figure 2B ). These findings oppose pharmacological 36 This study has limitations that may affect interpretation of results. 37 Nevertheless, these findings have clinical relevance for not only understanding how exercise plus weight loss regulates cytokines implicated in glucose regulation but also providing novel insight that may lay the groundwork for elucidating mechanisms involved in renal rehabilitation.
In conclusion, 12 weeks of aerobic exercise training with weight loss reduced soluble RAGE in previously sedentary, adults with CKD.
The decrease in soluble RAGE concentrations was associated with reductions in circulating postprandial blood glucose and elevations in insulin sensitivity. Given that hyperglycaemia is implicated in the development of vascular damage, these findings suggest that soluble RAGE may be an important cytokine related to macrovascular and microvascular complications related to end-stage organ damage in CKD. Further work is required to elucidate the mechanism whereby different RAGE variants relate to glucose metabolism in order to gain insight into how exercise with weight loss contributes to the prevention and/or reversal of type 2 diabetes and cardiovascular disease in patients with CKD. 
